Publication:
Editorial: The role of novel hepatitis B biomarkers in solving therapeutic dilemmas

dc.contributor.authorLazarevic, Ivana (23485928400)
dc.contributor.authorSvicher, Valentina (8632349900)
dc.contributor.authorCupic, Maja (15730255400)
dc.date.accessioned2025-06-12T12:25:49Z
dc.date.available2025-06-12T12:25:49Z
dc.date.issued2023
dc.description.abstract[No abstract available]
dc.identifier.urihttps://doi.org/10.3389/fmed.2023.1256109
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85167516508&doi=10.3389%2ffmed.2023.1256109&partnerID=40&md5=6a8ceac0ddac37bea7885927d3842a8d
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/3048
dc.subjectchronic hepatitis B (CHB)
dc.subjectHBcrAg
dc.subjectHBV biomarkers
dc.subjectHBV cccDNA
dc.subjectHBV RNA
dc.subjecthepatitis B virus (HBV)
dc.subjectnew diagnostic methods
dc.titleEditorial: The role of novel hepatitis B biomarkers in solving therapeutic dilemmas
dspace.entity.typePublication

Files